Qualified applicants must have an outstanding track record of successful independent experimental, epidemiological and/or clinical biomedical research, preferably in disease areas that predominantly affect women.
The successful candidate will develop an internationally recognised competitive research programme investigating the impact of environmental stressors (the exposome) on the prevention, pathogenesis and clinical outcomes of female-predominant diseases. They will collaborate closely with the Hôpital Fribourgeois (HFR), the University Hospital Lausanne (CHUV), the University Hospital Bern (Inselspital) and the École Polytechnique Fédérale de Lausanne (EPFL).
Significant teaching experience of human medicine at university level is mandatory. Courses are taught in French and/or German.
The successful candidate will also be responsible for establishing the envisioned Institute for Women's Health and Exposome at the University of Fribourg.
The closing date for applications is 15 January 2027. More information at www.unifr.ch/scimed/positions.
The University of Fribourg is bilingual (French/German). Knowledge of the second language (level B1 oral) is expected. If this is not the case, it must be acquired within two years of taking up the position.
Having signed the CoARA declaration, the University of Fribourg emphasizes qualitative assessment of academic achievements.
Seeking to promote an equitable representation of women and men, the University strongly encourages applications from women.
For further information, please contact dean-scimed@unifr.ch.


